The Concept of Interchangeability 

FDA approves the interchangeability of biosimilar products only after rigorous research and evaluation. Learn more with Leah Christl, Ph.D., Associate Director for Therapeutic Biologics and lead of the Office of New Drugs (OND) Therapeutic Biologics and Biosimilars staff at FDA CDER. For more information, visit www.FDA.gov/bi...